1. Home
  2. FOSL vs ALEC Comparison

FOSL vs ALEC Comparison

Compare FOSL & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fossil Group Inc.

FOSL

Fossil Group Inc.

HOLD

Current Price

$4.43

Market Cap

265.3M

ML Signal

HOLD

Logo Alector Inc.

ALEC

Alector Inc.

HOLD

Current Price

$1.50

Market Cap

245.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOSL
ALEC
Founded
1984
2013
Country
United States
United States
Employees
4500
N/A
Industry
Consumer Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
265.3M
245.4M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
FOSL
ALEC
Price
$4.43
$1.50
Analyst Decision
Strong Buy
Buy
Analyst Count
1
6
Target Price
$7.00
$4.83
AVG Volume (30 Days)
704.2K
703.1K
Earning Date
05-13-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$21,045,000.00
Revenue This Year
N/A
$2.03
Revenue Next Year
$1.66
$29.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$1.09
52 Week High
$5.75
$3.40

Technical Indicators

Market Signals
Indicator
FOSL
ALEC
Relative Strength Index (RSI) 55.12 26.79
Support Level $3.80 $1.14
Resistance Level $4.53 $1.60
Average True Range (ATR) 0.24 0.15
MACD 0.05 -0.04
Stochastic Oscillator 65.46 10.12

Price Performance

Historical Comparison
FOSL
ALEC

About FOSL Fossil Group Inc.

Fossil Group Inc is a design, innovation, and distribution company in consumer fashion accessories, offering products such as watches, jewelry, handbags, small leather goods, belts, and sunglasses. It designs, develops, markets, and distributes products under its owned brands FOSSIL, SKAGEN, MICHELE, RELIC, and ZODIAC. It operates through Americas, Europe, and Asia segments, each including sales to wholesale and distributor customers, as well as Company-owned retail stores and e-commerce activities based on the location of the selling entity. The Americas segment contributes the majority of revenue and includes sales across Canada, Latin America, and the United States, while the Europe and Asia segments cover their respective regions. Each segment provides similar products and services.

About ALEC Alector Inc.

Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.

Share on Social Networks: